Clinical trial
Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder
NCT02803229 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder
- Lead sponsor
- New York State Psychiatric Institute
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- July 31, 2016
- Completion date
- June 30, 2020
- Enrollment
- 33 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
attention-deficit/hyperactivity disorder, cannabis use disorder